CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer

Abstract

The initial phase of this study demonstrates that precision oncology on the basis of whole-genome and RNA sequencing is feasible when applied in the clinical management of patients with metastatic breast cancer and provides clinical benefit to a substantial proportion of patients.